Weill Cornell Medicine investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related molecule known as a sphingolipid, suggesting a promising new strategy for the treatment of coronary artery disease.
Households in Cambodia caught and consumed a far more diverse array of fish than they sold at market, highlighting how biodiversity loss might affect people’s nutrition, especially for those with lower incomes.
The exhibition "Seeds of Survival and Celebration: Plants and the Black Experience" returned for a second season with an expanded plant collection, which honors the lasting influence of the formerly enslaved and their descendants on American culture.
Home health aides are vulnerable to stress, isolation and depressive symptoms, which impact their own health as well as their patients’ desire to age in place, according new research.
Researchers at Weill Cornell Medicine have used machine learning to define three subtypes of Parkinson’s disease based on the pace at which the disease progresses.
The FDA has approved tirzepatide – which will be sold under the brand name Zepbound – to treat overweight and obesity. It’s the latest entrant into a field of powerful new drugs that includes Ozempic and Wegovy.
Scientists from Weill Cornell Medicine and the Dana-Farber Cancer Institute have developed new AI tools tailored to digital pathology, a growing field that uses high-resolution digital images created from tissue samples to help diagnose disease.
Women are at higher risk of death when undergoing heart bypass surgery than men, and researchers have determined that this disparity is mediated, to a large extent, by the loss of red blood cells during surgery.
The first-of-its-kind material not only expands and contracts like blood vessels but is also biodegradable; new vascular cells to grow around the graft as the body absorbs it.
A team led by Dr. Samie Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a three-year, $1.65 million grant for RNA research under a biotechnology-development program run by the U.S. National Science Foundation.
